Chemotherapy-Induced Nausea and Vomiting and Oral Chemotherapy Related Adverse Events

This activity provides an update for pharmacists on the antiemetic therapies available and techniques for managing the unique adverse events associated with oral chemotherapy. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Chronic Inflammatory Disease: An Introduction

This activity will review the pathophysiology and etiology of the inflammatory process along with identifying some of the pharmacological approaches to treating chronic inflammatory disease. This activity is available for free to NASP members. Visit the top section of www.ProCE.com/CSPE for details.

Colorectal Cancer

This activity will provide an overview of the epidemiology, risk factors, pathology, and staging of CRC. Common treatments used for CRC will be reviewed along with a discussion of adverse effects and recommended monitoring. Available for free to NASP members. Visit www.ProCE.com/CSPE for details.

Contemporary Evaluation and Management of Lung Cancer Targeted Therapies

The management of Lung Cancer is complex and pharmacists require a working knowledge or mastery of treatment options, including appropriateness of therapy, staging consideration, treatment failure, and associated adverse effects.

Contemporary Practice Pearls for Pulmonary Arterial Hypertension

This activity will focus on individualized treatment strategies for PAH therapy. Faculty will cover insights into PAH pathophysiology, therapies and the most recent data surrounding their uses, and navigating clinical guidelines.

COVID-19 Resources for Pharmacists: What You Really Need to Know

This activity is focused on COVID-19 and understanding the pharmacokinetics, proposed dosing, potential risks, adverse events, drug-drug interactions, and presumed benefits of off-label or investigational therapies.

Creating Impact in the Treatment and Prevention of Recurrent C. Difficile Infection

This activity will address patient education and counseling reminders to reduce the risk of recurrence, patient-specific risk factors for recurrent CDI, recommended and emerging treatments for recurrent CDI, and factors in health-system reduction of rCDI.

Cystic Fibrosis #1: An Overview for Pharmacists

Module 1 will provide an overview of CF disease. The metabolism differences to consider in CF patients will also be addressed. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Cystic Fibrosis #2: Chronic Medications: Changing the Course of Cystic Fibrosis

Module 2 reviews the chronic medications used in CF patients. It will also discuss some of the future directions being explored with medications for CF. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Cystic Fibrosis #3: Management of Acute Pulmonary Exacerbations: Pseudomonas and Beyond

Module 3 addresses the management of infections in CF patients and the use of antibiotics in CF patients. It will review the PK and PD considerations to in these patients. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.